Based on the aforementioned findings demonstrating the significant inhibition of NSCLC cell growth by ACADL in vitro, we proceeded to investigate the effect of ACADL on neoplasm growth in vivo using a mouse xenograft tumor model. This evidence concerns the gene ACADL and non-small cell lung carcinoma.